Lifevantage Profit Margin 2006-2019 | LFVN
Current and historical gross margin, operating margin and net profit margin for Lifevantage (LFVN) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Lifevantage net profit margin as of March 31, 2019 is 2.91%.
| Lifevantage Annual Profit Margins |
|---|
| Lifevantage Quarterly Profit Margins |
|---|
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $0.164B | $0.203B |
| Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Becton Dickinson (BDX) | United States | $61.596B | 20.52 |
| Align Technology (ALGN) | United States | $25.810B | 69.68 |
| McKesson (MCK) | United States | $23.745B | 9.20 |
| AmerisourceBergen (ABC) | United States | $16.337B | 11.60 |
| Laboratory Of America Holdings (LH) | United States | $16.194B | 15.14 |
| Cooper (COO) | United States | $14.453B | 25.21 |
| Cardinal Health (CAH) | United States | $13.422B | 8.69 |
| DENTSPLY SIRONA (XRAY) | United States | $12.735B | 26.55 |
| Henry Schein (HSIC) | United States | $10.125B | 17.02 |
| West Pharmaceutical Services (WST) | United States | $8.554B | 39.73 |
| Merit Medical Systems (MMSI) | United States | $3.019B | 31.37 |
| CONMED (CNMD) | United States | $2.268B | 36.18 |
| Patterson (PDCO) | United States | $2.098B | 16.58 |
| Atrion (ATRI) | United States | $1.638B | 46.78 |
| STAAR Surgical (STAA) | United States | $1.069B | 72.85 |
| Antares Pharma (ATRS) | United States | $0.457B | 0.00 |
| Invacare (IVC) | United States | $0.226B | 0.00 |
| Endologix (ELGX) | United States | $0.117B | 0.00 |
| Pro-Dex (PDEX) | United States | $0.057B | 17.64 |
| Biolase (BIOL) | United States | $0.040B | 0.00 |
| Retractable Technologies (RVP) | United States | $0.022B | 0.00 |
| Milestone Scientific (MLSS) | United States | $0.016B | 0.00 |
